NASH HOLDINGS, LLC

NASHVILLE, TN · Founded 2024 · CIK 0002055642 · Biotech

Clinical big data platform integrating genomics and medical imaging for biopharmaceutical and diagnostics R&D

nashbio.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$1.4M
1 Form D · Feb 2025
20 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$1,353,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1893OCATA THERAPEUTICS, INC.——
1894CELLECTAR, Inc.—$2.7M
1895SUNNYLIFE PHARMA INC.——
1896NASH HOLDINGS, LLC—$1.4M
1897Cybele Microbiome Inc—$1.6M
1898Direct Biologics, LLC—$12M
1899Inograft Biotherapeutics——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 1 related persons
  • JAMES BODNARExecutive Officer

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.